|
[Related PubMed/MEDLINE] Total Number of Papers: 305
|
|
|
[Display Entries]
|
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of
|
|
|
|
Abbreviation |
: LOX-1 |
Long Form |
: lectin-like oxidized low-density lipoprotein receptor-1 |
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2020 |
A modified laser-induced choroidal neovascularization animal model with intravitreal oxidized low-density lipoprotein. |
CCR2, CNV, IL-6, LDL, MMP9, oxLDL, PBS, qRT-PCR, RPE, VEGF, WB |
2 |
2020 |
Apremilast ameliorates ox-LDL-induced endothelial dysfunction mediated by KLF6. |
HAECs, IL-6, IL-8, JNK, KLF6, MCP-1, oxLDL, PDE4, TNF-alpha, VCAM-1 |
3 |
2020 |
Association between impaired cutaneous microvascular endothelial function and lectin-like oxidized low-density lipoprotein receptor-1 in patients with coronary slow flow. |
CSF, sLOX-1, TFC |
4 |
2020 |
Association Between Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 and Coronary Artery Disease in Psoriasis. |
CCTA, IQR, NCB, PASI, sLOX-1 |
5 |
2020 |
Baicalein exerts neuroprotective effect against ischaemic/reperfusion injury via alteration of NF-kB and LOX and AMPK/Nrf2 pathway. |
COX-2, I/R, NF-kB, PGE2 |
6 |
2020 |
Biomimetic 3D Models for Investigating the Role of Monocytes and Macrophages in Atherosclerosis. |
ECM, oxLDL |
7 |
2020 |
Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils. |
DES, EES, GM-CSF, MDSC, PD-1, PMN-MDSCs |
8 |
2020 |
Donepezil Prevents ox-LDL-Induced Attachment of THP-1 Monocytes to Human Aortic Endothelial Cells (HAECs). |
Egr-1, HAECs, ICAM-1, IL-6, oxLDL, TF, TNF-alpha |
9 |
2020 |
ERK1/2-PPARgamma pathway is involved in Chlamydia pneumonia-induced human umbilical vein endothelial cell apoptosis through increased LOX-1 expression. |
Cpn, HUVECs, PPARgamma |
10 |
2020 |
Evaluation of subclinical atherosclerosis in Turkish patients with acne vulgaris receiving systemic isotretinoin. |
oxLDL |
11 |
2020 |
Gynura procumbens ethanol extract and its fractions inhibit macrophage derived foam cell formation. |
ABCA1, ELISA, RT-qPCR |
12 |
2020 |
Human cytomegalovirus infection is correlated with atherosclerotic plaque vulnerability in carotid artery. |
CMV, MMP-9, TNF-alpha |
13 |
2020 |
Inhibition of LOX-1 prevents inflammation and photoreceptor cell death in retinal degeneration. |
LD, polyI |
14 |
2020 |
LNCRNA OIP5-AS1 regulates oxidative low-density lipoprotein-mediated endothelial cell injury via miR-320a/LOX1 axis. |
AS, CCK-8, ECs, LDH, miR-320a, oxLDL, qRT-PCR |
15 |
2020 |
LOX-1 (Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1) Deletion Has Protective Effects on Stroke in the Genetic Background of Stroke-Prone Spontaneously Hypertensive Rat. |
SHRSP |
16 |
2020 |
LOX-1 Regulates P. gingivalis-Induced Monocyte Migration and Adhesion to Human Umbilical Vein Endothelial Cells. |
CAMs, CCR2, HUVECs, ICAM-1, MCP-1, NF-kappaB, P. gingivalis |
17 |
2020 |
N-3 PUFAs inhibited hepatic ER stress induced by feeding of a high-saturated fat diet accompanied by the expression LOX-1. |
ER, HFD, NAFLD, PUFAs |
18 |
2020 |
Nerolidol inhibits the LOX-1 / IL-1beta signaling to protect against the Aspergillus fumigatus keratitis inflammation damage to the cornea. |
A. fumigatus, HCECs, IL-1beta, MIC, MPO, PBS, qRT-PCR |
19 |
2020 |
Oleacein and Foam Cell Formation in Human Monocyte-Derived Macrophages: A Potential Strategy Against Early and Advanced Atherosclerotic Lesions. |
ACAT1, GM-CSF, oxLDL, RT-PCR, SR-A1, WB |
20 |
2020 |
Oxidized low-density lipoproteins induce tissue factor expression in T-lymphocytes via activation of lectin-like oxidized low-density lipoprotein receptor-1. |
oxLDLs, ROS, TF |
21 |
2020 |
Sarpogrelate and rosuvastatin synergistically ameliorate aortic damage induced by hyperlipidemia in apolipoprotein E-deficient mice. |
HFD, IL, LDL |
22 |
2020 |
Serum LOX-1 is a novel prognostic biomarker of colorectal cancer. |
--- |
23 |
2020 |
Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 as a biomarker of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. |
aSAH, DCI, sLOX-1, WFNS |
24 |
2020 |
Stratification by Multidimensional Approach for Rational Treatment of Asymptomatic Carotid Stenosis (SMART-K Study): Study Protocol. |
ACS, CS, IPH, MRI |
25 |
2019 |
A Secreted Phospholipase A2 Induces Formation of Smooth Muscle Foam Cells Which Transdifferentiate to Macrophage-Like State. |
ACAT, AcLDL, DGAT, GIIA sPLA2s, LDs, MT-III, PPARs, SR-A1, VSMCs |
26 |
2019 |
Apolipoprotein E Deficiency Causes Endothelial Dysfunction in the Mouse Retina. |
--- |
27 |
2019 |
C-terminus of heat shock protein 60 can activate macrophages by lectin-like oxidized low-density lipoprotein receptor 1. |
APCs, HSP60C, MAPK, MyD88, OVA, TLR |
28 |
2019 |
Celastrol ameliorates Aspergillus fumigatus keratitis via inhibiting LOX-1. |
A. fumigatus, CLT |
29 |
2019 |
CRP and LOX-1: a Mechanism for Increasing the Tumorigenic Potential of Colorectal Cancer Carcinoma Cell Line. |
CRC, CRP, oxLDL |
30 |
2019 |
Deleterious role of endothelial lectin-like oxidized low-density lipoprotein receptor-1 in ischaemia/reperfusion cerebral injury. |
eLOX-1TG, I/R, siRNA, tMCAO, WT |
31 |
2019 |
Depletion of CPEB1 protects against oxidized LDL-induced endothelial apoptosis and inflammation though SIRT1/LOX-1 signalling pathway. |
AS, Co-IP, CPEB1, JNK, oxLDL, siRNA, SIRT1 |
32 |
2019 |
Design and Development of Novel 1,3,5-Triazine-Procaine Derivatives as Protective Agent against Myocardial Ischemia/Reperfusion Injury via Inhibitor of Nuclear Factor-kappaB. |
Bax, Bcl-2, CAT, CF, GPx, HR, I/R, LPS, LVDP, NF-kappaB, SOD, TBARS |
33 |
2019 |
Design and Synthesis of PEG-Oligoglycerol Sulfates as Multivalent Inhibitors for the Scavenger Receptor LOX-1. |
oxLDL, PEG |
34 |
2019 |
Emerging Biomarkers of Oxidative Stress in Acute and Stable Coronary Artery Disease: Levels and Determinants. |
ACS, AMI, CAD, CV, OS, ROM |
35 |
2019 |
Exosomal miRNA Let-7 from Menstrual Blood-Derived Endometrial Stem Cells Alleviates Pulmonary Fibrosis through Regulating Mitochondrial DNA Damage. |
IPF, MenSCs, mtDNA, NTA, ROS, TEM |
36 |
2019 |
Higher serum lectin-like oxidized low-density lipoprotein receptor-1 in patients with stable coronary artery disease is associated with major adverse cardiovascular events: A multicentre pilot study. |
ACS, CAD, ELISA, MACE, sLOX-1 |
37 |
2019 |
Inhibition of LOX-1 alleviates the proinflammatory effects of high-mobility group box 1 in Aspergillus fumigatus keratitis. |
A. fumigatus, HMGB1, IL-1beta, MIP-2, PBS, TNF-alpha |
38 |
2019 |
Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Levels as a Biomarker of Acute Intracerebral Hemorrhage. |
ICH |
39 |
2019 |
Lipoprotein Receptor Signaling in Atherosclerosis. |
ApoER2, CD36, LDLR, LRP, SR-BI, VLDLR |
40 |
2019 |
LOX-1 and atherosclerotic-related diseases. |
ACS, CAD, oxLDL |
41 |
2019 |
LOX-1, the Common Therapeutic Target in Hypercholesterolemia: A New Perspective of Antiatherosclerotic Action of Aegeline. |
AG, AV, HCD, oxLDL |
42 |
2019 |
LOX-1: Its cytotopographical variance and disease stress. |
oxLDL |
43 |
2019 |
Microglial LOX-1/MAPKs/NF-kappaB positive loop promotes the vicious cycle of neuroinflammation and neural injury. |
CNS |
44 |
2019 |
Naringin Reverses High-Cholesterol Diet-Induced Vascular Dysfunction and Oxidative Stress in Rats via Regulating LOX-1 and NADPH Oxidase Subunit Expression. |
4-HNE, ACh, DHE, iNOS, NADPH, NO |
45 |
2019 |
OxHDL controls LOX-1 expression and plasma membrane localization through a mechanism dependent on NOX/ROS/NF-kappaB pathway on endothelial cells. |
oxHDL |
46 |
2019 |
Peroxisome Proliferator-Activated Receptor-gamma Antagonizes LOX-1-Mediated Endothelial Injury by Transcriptional Activation of miR-590-5p. |
HUVECs, TZD |
47 |
2019 |
Pro-oncogenic action of LOX-1 and its splice variant LOX-1Delta4 in breast cancer phenotypes. |
--- |
48 |
2019 |
Requisite roles of LOX-1, JNK, and arginase in diabetes-induced endothelial vasodilator dysfunction of porcine coronary arterioles. |
NO |
49 |
2019 |
Serum Levels of Carbamylated LDL and Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Are Associated with Coronary Artery Disease in Patients with Metabolic Syndrome. |
AUC, CAD, CI, cLDL, HDL, MetS, OR, ROC, sLOX-1 |
50 |
2019 |
Serum Levels of Carbamylated LDL, Nitrotyrosine and Soluble Lectin-like Oxidized Low-density Lipoprotein Receptor-1 in Poorly Controlled Type 2 Diabetes Mellitus. |
cLDL, NT, sLOX-1, T2DM |
51 |
2019 |
The association between local arteriosclerosis of the prostatic arteries and chronic inflammation in human benign prostatic enlargement. |
BPE, IBA1, RARP |
52 |
2019 |
Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis. |
oxLDL |
53 |
2019 |
[Effect and mechanism of PCSK9 on lectin-like oxidized low-density lipoprotein receptor-1 mediated oxidized low-density lipoprotein uptake by THP-1 derived macrophages]. |
COX-2, NADPH, NF-kappaB, oxLDL, ROS, TLR4 |
54 |
2019 |
[Gly14]-Humanin Prevents Lipid Deposition and Endothelial Cell Apoptosis in a Lectin-like Oxidized Low-density Lipoprotein Receptor-1-Dependent Manner. |
HN, HUVEC, oxLDL |
55 |
2018 |
Alterations in vascular function by syncytiotrophoblast extracellular vesicles via lectin-like oxidized low-density lipoprotein receptor-1 in mouse uterine arteries. |
AT1, AT2, GD, HUVECs, LOX-1-KO, MCh, NO, STBEVs |
56 |
2018 |
Cinnamaldehyde protects VSMCs against ox-LDL-induced proliferation and migration through S arrest and inhibition of p38, JNK/MAPKs and NF-kappaB. |
CIN, HO-1, MCP-1, MMP-2, VSMCs |
57 |
2018 |
Clinical analysis of lectin-like oxidized low-density lipoprotein receptor-1 in patients with in-stent restenosis after percutaneous coronary intervention. |
AUC, CAG, CREA, HDL-C, ISR, PCI, ROC, UA |
58 |
2018 |
Ecrg4 peptide is the ligand of multiple scavenger receptors. |
ECRG4, TLRs |
59 |
2018 |
Enhanced Bioactivity of the Anti-LOX-1 scFv Engineered by Multimerization Strategy. |
scFv |
60 |
2018 |
Expression of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Human Epicardial and Intramyocardial Coronary Arteries of Male Patients Undergoing Coronary Artery Bypass Grafting. |
--- |
61 |
2018 |
Fluid shear stress regulates the expression of Lectin-like oxidized low density lipoprotein receptor-1 via KLF2-AP-1 pathway depending on its intensity and pattern in endothelial cells. |
AP-1, ECs, FSS, KLF2, LSS, OSS |
62 |
2018 |
LOX-1 mediated phenotypic switching of pulmonary arterial smooth muscle cells contributes to hypoxic pulmonary hypertension. |
PASMCs, PH |
63 |
2018 |
LOX-1 receptor: A potential link in atherosclerosis and cancer. |
oxLDL, ROS |
64 |
2018 |
Polyphenols from Ilex latifolia Thunb. (a Chinese bitter tea) exert anti-atherosclerotic activity through suppressing NF-kappaB activation and phosphorylation of ERK1/2 in macrophages. |
CD36, IL, iNOS, LC-MS, oxLDL |
65 |
2018 |
Protective Effects of Chinese Traditional Medicine Longhu Rendan against Atherosclerosis via Negative Regulation of LOX-1. |
LDL-C, LHRD, TC, TG |
66 |
2018 |
Role of vasoactive intestinal peptide in Aspergillus fumigatus-infected cornea. |
A. fumigatus, ELISA, IL-1beta, MPO, p.i, PCR, TLR4, TNF-alpha, VIP |
67 |
2018 |
Thymoquinone reduces cardiac damage caused by hypercholesterolemia in apolipoprotein E-deficient mice. |
hs-CRP, LDL-C, TC |
68 |
2018 |
Toll-like receptor 2 activation primes and upregulates osteoclastogenesis via lox-1. |
BMCs, BMMs, FACS, LPS, MAPK, MyD88, OCs, oxLDL, PCR, RANKL, TLR, TRAP |
69 |
2017 |
Association of angiotensin II receptor 1 and lectin-like oxidized low-density lipoprotein receptor-1 mediates the cardiac hypertrophyinduced by oxidized low-density lipoprotein. |
oxLDL |
70 |
2017 |
Contribution of lectin-like oxidized low-density lipoprotein receptor-1 and LOX-1 modulating compounds to vascular diseases. |
oxLDL |
71 |
2017 |
Expression and Characterization of a Single-Chain Variable Fragment against Human LOX-1 in Escherichia coli and Brevibacillus choshinensis. |
B. choshinensis, E. coli, scFv |
72 |
2017 |
Free Fatty Acids Induce Autophagy and LOX-1 Upregulation in Cultured Aortic Vascular Smooth Muscle Cells. |
FFAs, OA, PA, VSMCs |
73 |
2017 |
Involvement of epithelial-mesenchymal transition afforded by activation of LOX-1/ TGF-beta1/KLF6 signaling pathway in diabetic pulmonary fibrosis. |
EMT, HBECs, HE, KLF6, STZ, TGF-beta1 |
74 |
2017 |
Lectin-like oxidized low-density lipoprotein receptor-1 facilitates metastasis of gastric cancer through driving epithelial-mesenchymal transition and PI3K/Akt/GSK3beta activation. |
GC |
75 |
2017 |
Lectin-like oxidized low-density lipoprotein receptor-1 promotes endothelial dysfunction in LDL receptor knockout background. |
CD, WD, WT |
76 |
2017 |
LOX-1 in Atherosclerosis and MyocardialIschemia: Biology, Genetics, and Modulation. |
ox-LDL |
77 |
2017 |
LOX-1 promotes right ventricular hypertrophy in hypoxia-exposed rats. |
ANP, BNP, NOX, ROS, RVH |
78 |
2017 |
MicroRNA-98 rescues proliferation and alleviates ox-LDL-induced apoptosis in HUVECs by targeting LOX-1. |
ECs, HUVECs, miR-98, miRNAs, oxLDL |
79 |
2017 |
Porphyromonas gingivalis Infection Accelerates Atherosclerosis Mediated by Oxidative Stress and Inflammatory Responses in ApoE-/- Mice. |
APOE, CRP, FAS, iNOS, NF-kappaB, NOX, oxLDL, P. gingivalis, ROS, VLDL |
80 |
2017 |
Possible involvement of the oxLDL/LOX-1 system in the pathogenesis and progression of human intervertebral disc degeneration or herniation. |
IVDD, IVDs, MMP3, NP, NPCs, oxLDL |
81 |
2017 |
Syncytiotrophoblast extracellular vesicles impair rat uterine vascular function via the lectin-like oxidized LDL receptor-1. |
STBEVs |
82 |
2017 |
The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Reduces Aortic Damage from Hypercholesterolaemia in Apolipoprotein E-Deficient Mice. |
--- |
83 |
2017 |
The lipid moiety 7-ketocholesteryl-9-carboxynonanoate mediates binding interaction of oxLDL to LOX-1 and upregulates ABCA1 expression through PPARgamma. |
ELISAs, oxLDL |
84 |
2016 |
Coronary Microembolization Induces Cardiomyocyte Apoptosis in Swine by Activating the LOX-1-Dependent Mitochondrial Pathway and Caspase-8-Dependent Pathway. |
CME, siRNA |
85 |
2016 |
Efficacy of Oral Curcuminoid Fraction from Curcuma xanthorrhiza and Curcuminoid Cider in High-cholesterol Fed Rats. |
CD44, HCD, ICAM-1, iNOS, PCR |
86 |
2016 |
Ghrelin inhibits oxLDL-induced inflammation in RAW264.7 mouse macrophages through down-regulation of LOX-1 expression via NF-kappaB signaling pathway. |
IL, oxLDL, TNF |
87 |
2016 |
High Levels of Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Acute Stroke: An Age- and Sex-Matched Cross-Sectional Study. |
CI, ICH, OR, sLOX-1 |
88 |
2016 |
Inhibition of lectin-like oxidized low-density lipoprotein receptor-1 reduces cardiac fibroblast proliferation by suppressing GATA Binding Protein 4. |
CFs, GATA4 |
89 |
2016 |
LOX-1-Mediated Effects on Vascular Cells in Atherosclerosis. |
ECs, oxLDL, VSMCs |
90 |
2016 |
Osteopontin deficiency reduces kidney damage from hypercholesterolemia in Apolipoprotein E-deficient mice. |
CKD, HD, ND, OPN, PAS, rmOPN |
91 |
2016 |
Overexpression of LOXIN Protects Endothelial Progenitor Cells From Apoptosis Induced by Oxidized Low Density Lipoprotein. |
hEPC, oxLDL |
92 |
2016 |
Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis. |
CV, oxLDL, SRs, TLRs |
93 |
2016 |
Rapamycin Inhibits Oxidized Low Density Lipoprotein Uptake in Human Umbilical Vein Endothelial Cells via mTOR/NF-kappaB/LOX-1 Pathway. |
HUVECs, mTOR, oxLDL |
94 |
2016 |
Roles of LOX-1 in microvascular dysfunction. |
--- |
95 |
2016 |
The human rs1050286 polymorphism alters LOX-1 expression through modifying miR-24 binding. |
A/G, AMI, CAD, SNP |
96 |
2016 |
The relationship between serum lectin-like oxidized LDL receptor-1 levels and systolic heart failure. |
EF |
97 |
2015 |
1,25-dihydroxyvitamin D3 causes ADAM10-dependent ectodomain shedding of tumor necrosis factor receptor 1 in vascular smooth muscle cells. |
ADAM, TNF-alpha, TNFR1 |
98 |
2015 |
Association between plasma sLOX-1 concentration and arterial stiffness in middle-aged and older individuals. |
sLOX-1 |
99 |
2015 |
Atorvastatin protects cardiomyocytes from oxidative stress by inhibiting LOX-1 expression and cardiomyocyte apoptosis. |
ACS, CAD |
100 |
2015 |
Coronary Microembolization Induces Cardiomyocyte Apoptosis Through the LOX-1-Dependent Endoplasmic Reticulum Stress Pathway Involving JNK/P38 MAPK. |
CHOP, CME, ER, GRP78, JNK, LAD, MAPK, siRNA |
|